Blog

T cells

Building CGT’s Clinical Trial Potential: PRA’s Partnership with Cell and Gene Therapy Supply Chain Software Leader Vineti

Key Highlights: PRA’s partnership with Vineti will optimize clinical trial delivery, clinical study operations and data management, and commercialization readiness…

Read More
June 15, 2021

PRA Health Sciences Announces Partnership with Vineti

RALEIGH, NC and SAN FRANCISCO, CA, June 15, 2021 — PRA Health Sciences and Vineti, Inc., today announced a new...

May 27, 2021

Ori Biotech and Vineti Form Strategic Partnership to Deliver Integrated Manufacturing and Supply Chain Solutions for Cell and Gene Therapies

Platform integration will provide therapy developers with full end-to-end visibility, control, and insights into manufacturing and supply chain LONDON and...

May 12, 2021

Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution

New PTM Essentials™ solution draws on Vineti’s industry-leading Personalized Therapy Management® (PTM) software platform to deliver breakthrough speed and simplicity for advanced...

April 22, 2021

Advanced Therapies Guide – seven key challenges and proven solutions – in advanced therapy clinical trials

Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...

March 26, 2021

A new Five-minute Guide — seven key challenges in advanced therapy clinical trials

Advanced therapies emerge from advanced science — and must overcome the operational complexity inherent in their patient-centric paradigm when they...

March 25, 2021

Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies

Genentech, Takeda, Adaptimmune and other industry leaders join Vineti to form the core of this strategic collaboration. The group is...

March 24, 2021

Repost: a modern patient ID for personalized medicine

Today, Vineti released an announcement about new industry collaboration around our proposal for a new patient ID for cell and gene therapies....

February 3, 2021

A fresh start for advanced therapy clinical trials

A look at 2020 and the coming rebound, by the numbers Even before the unpredictable year that was 2020, one...

January 11, 2021

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...

January 4, 2021

The Vineti Alliance Network — a preview of what’s next

For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One...

December 15, 2020

How PTM® Label Printing keeps every patient journey on track

In advanced therapies, little labels — the in-process labels on bags of cells and final drug products — can sometimes...

November 30, 2020

A true platform is the engine for advanced therapies

A Vineti technology perspective from Chief Technology Officer Phil Calvin Phil Calvin, Vineti’s Chief Technology Officer, is a long-time leader...